NSC | Compound | Enrichment | Correlation |
---|---|---|---|
NSC 711014 | Null | 0.00526022686151168 | -0.018543117 |
NSC 718812 | Null | 0.00526022686151168 | 0.40694813 |
NSC 723741 | Diethyl N-[4-[(3-phenyl-5,7-diaminoquinoxalin-2-yl)hydroxy]benzoyl]- L-glutamate | 0.00526022686151168 | 0.072794009 |
NSC 737318 | 6-(3-Chloropropyl)-5,6-dihydro-2,3,9-trimethoxy-5,11-dioxo-1 1H-indeno[1,2-c]isoquinoline | 0.00526022686151168 | -0.096263502 |
NSC 750039 | Null | 0.00526022686151168 | 0.57120791 |
NSC 107043 | Null | 0.00559873245069076 | 0.02305949 |
NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.00559873245069076 | 0.30604365 |
NSC 133118 | 2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) | 0.00559873245069076 | -0.13955378 |
NSC 295499 | Camptothecin Derivative | 0.00559873245069076 | 0.056117577 |
NSC 330507 | Tanespimycin | 0.00559873245069076 | 0.10601168 |